Subsequently, this observation was extended to a cohort of 338 NSCLC patients, whereby the presence of A. muciniphila in the stool of patients had a prognostic impact on anti-PD-1 therapy independently of gender, age, and PD-L1 expression [32]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.